SARS-CoV-2 spike protein rabbit monoclonal antibody, clone OTIR4G5
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 spike protein rabbit monoclonal antibody, clone OTIR4G5
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
CNY 1999.00
CNY 4070.00
2周
SARS-Cov-2 N protein Rabbit monoclonal antibody, clone OTIR11A9
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
CNY 1999.00
CNY 4070.00
2周
SARS-Cov-2 N protein Rabbit monoclonal antibody, clone OTIR12C7
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
CNY 1999.00
CNY 4070.00
2周
SARS-Cov-2 N protein Rabbit monoclonal antibody, clone OTIR4D12
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 spike protein rabbit monoclonal antibody, clone OTIR2C2
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 spike protein rabbit monoclonal antibody, clone OTIR2G7
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 spike protein rabbit monoclonal antibody, clone OTIR2F9
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 spike protein rabbit monoclonal antibody, clone OTIR4A8
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 spike protein rabbit monoclonal antibody, clone OTIR4A11
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 spike protein rabbit monoclonal antibody, clone OTIR6A3
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 spike protein rabbit monoclonal antibody, clone OTIR7A8
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 spike protein rabbit monoclonal antibody, clone OTIR6G7
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
CNY 1999.00
CNY 3600.00
现货
SARS-CoV-2 Spike protein mouse monoclonal antibody, clone OTI1H6
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
CNY 1999.00
CNY 3600.00
现货
SARS-CoV-2 Spike protein mouse monoclonal antibody, clone OTI5A7
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 Spike protein mouse monoclonal antibody, clone OTI1H6
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |